{"id":"https://openalex.org/W7225738070","doi":"https://doi.org/10.1186/s43066-026-00570-z","title":"P53-mediated apoptosis and topoisomerase II\u03b1 inhibition by an acridine derivative in hepatocellular carcinoma","display_name":"P53-mediated apoptosis and topoisomerase II\u03b1 inhibition by an acridine derivative in hepatocellular carcinoma","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225738070","doi":"https://doi.org/10.1186/s43066-026-00570-z"},"language":"en","primary_location":{"id":"doi:10.1186/s43066-026-00570-z","doi":"https://doi.org/10.1186/s43066-026-00570-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s43066-026-00570-z","pdf_url":null,"source":{"id":"https://openalex.org/S2764852108","display_name":"Egyptian Liver Journal","issn_l":"2090-6218","issn":["2090-6218","2090-6226"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Egyptian Liver Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1186/s43066-026-00570-z","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112787777","display_name":"Aneel Ahmed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdullah A. S. Ahmed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103903614","display_name":"Ibrahim El\u2010Tantawy El\u2010Sayed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ibrahim El-Tantawy El-Sayed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107948231","display_name":"Tamer A. Addissouky","orcid":"https://orcid.org/0000-0003-3797-9155","observed_orcids":["https://orcid.org/0000-0003-3797-9155"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tamer A. Addissouky","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3797-9155","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099521312","display_name":"Esraa Nazieh El-Bery","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esraa Nazieh El-Bery","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067918763","display_name":"Islam M. El\u2010Garawani","orcid":"https://orcid.org/0000-0002-7241-4910","observed_orcids":["https://orcid.org/0000-0002-7241-4910"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Islam M. El-Garawani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161385678","display_name":"Nermeen M. El-Nahass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nermeen M. El-Nahass","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071757509","display_name":"Hany S. Ahmed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hany S. Ahmed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067768495","display_name":"Yasmine S. Moemen","orcid":"https://orcid.org/0000-0003-3173-7155","observed_orcids":["https://orcid.org/0000-0003-3173-7155"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasmine S. Moemen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069792156","display_name":"Heba M. R. Hathout","orcid":"https://orcid.org/0000-0002-5084-8603","observed_orcids":["https://orcid.org/0000-0002-5084-8603"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heba M. R. Hathout","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7827000021934509,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7827000021934509,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.06279999762773514,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0625,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.7261000275611877},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.6107000112533569},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5837000012397766},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5591999888420105},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.5199000239372253},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.48100000619888306},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4440000057220459},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.429500013589859},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41999998688697815},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4115999937057495},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.40130001306533813},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39820000529289246},{"id":"https://openalex.org/C2909829705","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin Hydrochloride","level":4,"score":0.3968999981880188},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.3856000006198883},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.3855000138282776},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.3515999913215637},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.33070001006126404},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.3285999894142151},{"id":"https://openalex.org/C2778616834","wikidata":"https://www.wikidata.org/wiki/Q281044","display_name":"Topoisomerase inhibitor","level":4,"score":0.32120001316070557},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.31139999628067017},{"id":"https://openalex.org/C2910410043","wikidata":"https://www.wikidata.org/wiki/Q342713","display_name":"Acridine derivatives","level":2,"score":0.3059000074863434},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.29600000381469727},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2939000129699707},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.2874000072479248},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.2784999907016754},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.27799999713897705},{"id":"https://openalex.org/C2776924795","wikidata":"https://www.wikidata.org/wiki/Q342713","display_name":"Acridine","level":2,"score":0.272599995136261},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.26980000734329224},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.26570001244544983}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1186/s43066-026-00570-z","doi":"https://doi.org/10.1186/s43066-026-00570-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s43066-026-00570-z","pdf_url":null,"source":{"id":"https://openalex.org/S2764852108","display_name":"Egyptian Liver Journal","issn_l":"2090-6218","issn":["2090-6218","2090-6226"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Egyptian Liver Journal","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1186/s43066-026-00570-z","doi":"https://doi.org/10.1186/s43066-026-00570-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s43066-026-00570-z","pdf_url":null,"source":{"id":"https://openalex.org/S2764852108","display_name":"Egyptian Liver Journal","issn_l":"2090-6218","issn":["2090-6218","2090-6226"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Egyptian Liver Journal","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":87,"referenced_works":["https://openalex.org/W1976487335","https://openalex.org/W1983319354","https://openalex.org/W2011703027","https://openalex.org/W2036797428","https://openalex.org/W2039124321","https://openalex.org/W2043510752","https://openalex.org/W2046812449","https://openalex.org/W2053277232","https://openalex.org/W2072169703","https://openalex.org/W2084482878","https://openalex.org/W2398116906","https://openalex.org/W2529000169","https://openalex.org/W2594684291","https://openalex.org/W2598444026","https://openalex.org/W2618229240","https://openalex.org/W2670351645","https://openalex.org/W2730743035","https://openalex.org/W2745502933","https://openalex.org/W2747910580","https://openalex.org/W2755482844","https://openalex.org/W2788640168","https://openalex.org/W2883860328","https://openalex.org/W2888944634","https://openalex.org/W2912118588","https://openalex.org/W2947881982","https://openalex.org/W2969751074","https://openalex.org/W2972411752","https://openalex.org/W2982215004","https://openalex.org/W3002575192","https://openalex.org/W3008880580","https://openalex.org/W3026474399","https://openalex.org/W3044145717","https://openalex.org/W3049406574","https://openalex.org/W3092930775","https://openalex.org/W3099956633","https://openalex.org/W3109134151","https://openalex.org/W3111995113","https://openalex.org/W3119086885","https://openalex.org/W3120547932","https://openalex.org/W3121640577","https://openalex.org/W3152598664","https://openalex.org/W3152819102","https://openalex.org/W4206043150","https://openalex.org/W4210675874","https://openalex.org/W4211001831","https://openalex.org/W4221022290","https://openalex.org/W4283023609","https://openalex.org/W4293116267","https://openalex.org/W4307568539","https://openalex.org/W4307947791","https://openalex.org/W4308118396","https://openalex.org/W4308365352","https://openalex.org/W4311789091","https://openalex.org/W4317243039","https://openalex.org/W4319063485","https://openalex.org/W4327571871","https://openalex.org/W4362068865","https://openalex.org/W4383819127","https://openalex.org/W4387965015","https://openalex.org/W4388494161","https://openalex.org/W4389224881","https://openalex.org/W4390340120","https://openalex.org/W4391531716","https://openalex.org/W4393258819","https://openalex.org/W4396803559","https://openalex.org/W4399940463","https://openalex.org/W4400090449","https://openalex.org/W4403978481","https://openalex.org/W4404034673","https://openalex.org/W4404115069","https://openalex.org/W4407144003","https://openalex.org/W4407414339","https://openalex.org/W4407830436","https://openalex.org/W4407945078","https://openalex.org/W4410515898","https://openalex.org/W4411211114","https://openalex.org/W4413387888","https://openalex.org/W4413753231","https://openalex.org/W4414025865","https://openalex.org/W4414169003","https://openalex.org/W4415720668","https://openalex.org/W7124166024","https://openalex.org/W7139956349","https://openalex.org/W7154206400","https://openalex.org/W7168482746","https://openalex.org/W7171426114","https://openalex.org/W7202085076"],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Primary":[2],"liver":[3],"malignancy":[4],"represents":[5],"a":[6,53,240,280],"significant":[7,260],"worldwide":[8],"health":[9],"burden":[10],"characterized":[11],"by":[12,110],"restricted":[13],"therapeutic":[14,36,282],"alternatives":[15],"and":[16,38,48,72,92,105,118,175,181,192,199,225,250,269],"elevated":[17],"relapse":[18],"frequencies.":[19],"While":[20],"acridine-based":[21],"compounds":[22],"have":[23],"demonstrated":[24],"promising":[25,251],"bioactive":[26],"properties":[27,47,263],"including":[28],"anticancer":[29],"capabilities,":[30],"challenges":[31],"persist":[32],"in":[33,70,273],"enhancing":[34],"their":[35],"efficacy":[37],"target":[39],"specificity.":[40],"Purpose":[41],"This":[42],"investigation":[43,278],"evaluated":[44],"the":[45,78,119,138,193,207,210],"antineoplastic":[46,262],"underlying":[49],"molecular":[50,129],"mechanisms":[51],"of":[52,100,115,189,209,253],"newly":[54],"synthesized":[55],"acridine":[56],"hydrochloride":[57,60],"compound,":[58],"N-(3-(4-(3-aminopropyl)piperazin-1-yl)propyl)acridin-9-amine":[59],"(9-BAPPA),":[61],"targeting":[62],"HepG2":[63,73,152,274],"hepatocellular":[64],"carcinoma":[65],"cells.":[66],"Methods":[67],"Cell":[68,81],"viability":[69],"NHPL":[71,164],"cells":[74,153,165,171],"was":[75,83,108,134],"determined":[76],"using":[77,124],"MTT":[79],"assay.":[80],"death":[82],"showed":[84,147,246],"both":[85,197],"morphologically":[86],"with":[87,94,131,158],"fluorescent":[88],"double":[89],"staining":[90],"(AO/EB)":[91],"biochemically":[93],"flow":[95],"cytometry":[96],"analysis.":[97],"The":[98],"levels":[99,201],"p53,":[101,116,190],"BCL-2,":[102],"BAX,":[103],"caspase-3,":[104,117,191],"PCNA":[106],"proteins":[107],"assessed":[109],"immunocytochemistry,":[111],"while":[112],"mRNA":[113,198],"expression":[114],"BAX/BCL-2":[120,194],"ratio":[121,195],"were":[122],"measured":[123],"qRT":[125],"PCR.":[126],"In":[127,144,243],"addition,":[128],"docking":[130,217],"topoisomerase":[132,234],"II\u03b1":[133],"performed":[135],"to":[136],"explore":[137],"compound\u2019s":[139],"predicted":[140],"binding":[141,221],"mode.":[142],"Results":[143],"vitro":[145],"assays":[146],"that":[148],"9-BAPPA":[149,224,258],"selectively":[150],"inhibited":[151],"(IC\u2085\u2080":[154,166],"=":[155,167],"15.2":[156],"\u00b5g/mL)":[157],"much":[159],"lower":[160],"toxicity":[161],"toward":[162],"normal":[163],"34.3":[168],"\u00b5g/mL).":[169],"Treated":[170],"exhibited":[172],"apoptotic":[173,266],"morphology":[174],"cell":[176,270],"cycle":[177,271],"arrest":[178],"at":[179,196],"sub-G\u2080/G\u2081":[180],"G\u2082/M":[182],"phases":[183],"(":[184,202],"p":[185,203],"<":[186],"0.0001).":[187],"Upregulation":[188],"protein":[200],"\u2264":[204],"0.01)":[205],"confirmed":[206],"activation":[208,268],"intrinsic":[211],"p53-dependent":[212],"mitochondrial":[213],"apoptosis":[214],"pathway.":[215],"Computational":[216],"analyses":[218],"revealed":[219],"robust":[220],"interactions":[222],"between":[223],"essential":[226],"residues":[227],"(MET":[228],"762,":[229],"MET":[230],"766,":[231],"Q778)":[232],"within":[233],"II\u03b1,":[235],"confirming":[236],"its":[237],"mechanism":[238],"as":[239,279],"topoisomerase-interfering":[241],"compound.":[242],"silico":[244],"Pharmacokinetics":[245],"good":[247],"oral":[248],"bioavailability":[249],"permeability":[252],"Blood":[254],"Brain":[255],"Barrier.":[256],"Conclusion":[257],"exhibits":[259],"selective":[261],"through":[264],"P53-mediated":[265],"pathway":[267],"disruption":[272],"cells,":[275],"warranting":[276],"additional":[277],"potential":[281],"compound":[283],"for":[284],"hepatic":[285],"malignancies.":[286]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}